SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-17-067982
Filing Date
2017-11-13
Accepted
2017-11-13 16:27:43
Documents
7
Period of Report
2017-11-09
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a17-26450_18k.htm 8-K 36409
2 EX-1.1 a17-26450_1ex1d1.htm EX-1.1 139156
3 EX-5.1 a17-26450_1ex5d1.htm EX-5.1 11198
4 EX-99.1 a17-26450_1ex99d1.htm EX-99.1 11067
5 GRAPHIC g264501kii001.gif GRAPHIC 2291
6 GRAPHIC g264501kii002.gif GRAPHIC 644
7 GRAPHIC g264501kii003.gif GRAPHIC 634
  Complete submission text file 0001104659-17-067982.txt   204450
Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940
Business Address 375 PHEASANT RUN NEWTOWN PA 18940 267-759-3681
Onconova Therapeutics, Inc. (Filer) CIK: 0001130598 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36020 | Film No.: 171196263
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1